QI
AGN

Qtron Investments’s Allergan plc AGN Stock Holding History

Qtron Investments’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-2,385
Closed -$399K – 287
2019
Q2 		$399K Hold
2,385
– – 0.25% 136
2019
Q1 		$349K Sell
2,385
-15
-0.6% -$2.17K 0.32% 90
2018
Q4 		$321K Buy
+2,400
New +$393K 0.25% 79

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Qtron Investments's AGN Position: Q3 2019 in Review

Qtron Investments sold out of Allergan plc (AGN) in Q3 2019, closing a stake of 2,385 shares — an estimated $399K sold.

Qtron Investments first reported a position in AGN in Q4 2018 and held it in 3 quarters. The position peaked at $399K in Q2 2019. 921 funds tracked by Wall St. Rank hold AGN as of Q3 2019.

  • Qtron Investments reported no remaining Allergan plc position as of Q3 2019 after selling out during the quarter.
  • Qtron Investments sold 2,385 Allergan plc shares in Q3 2019, an estimated $399K.
  • Qtron Investments first reported a position in Allergan plc in Q4 2018 and held it in 3 quarters.
  • Qtron Investments's Allergan plc position peaked at $399K in Q2 2019.
  • 921 funds tracked by Wall St. Rank held Allergan plc as of Q3 2019.

Based on Qtron Investments's 13F filing for Q3 2019, filed 12 Nov 2019.